Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/40581| metadata.artigo.dc.title: | A human monoclonal antibody blocking SARS-CoV-2 infection |
| metadata.artigo.dc.creator: | Wang, Chunyan Li, Wentao Drabek, Dubravka Okba, Nisreen M. A. van Haperen, Rien Osterhaus, Albert D. M. E. van Kuppeveld, Frank J. M. Haagmans, Bart L. Grosveld, Frank Bosch, Berend-Jan |
| metadata.artigo.dc.subject: | COVID-19 - Treatment Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Monoclonal antibody |
| metadata.artigo.dc.publisher: | Springer Nature |
| metadata.artigo.dc.date.issued: | 2020 |
| metadata.artigo.dc.identifier.citation: | WANG, C. et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nature Communications, [S.l.], v. 11, 2020. |
| metadata.artigo.dc.description.abstract: | The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19. |
| metadata.artigo.dc.identifier.uri: | https://www.nature.com/articles/s41467-020-16256-y http://repositorio.ufla.br/jspui/handle/1/40581 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.